Erythema annulare centrifugum-like eruption associated with pegylated interferon treatment for hepatitis C

Current standard of treatment for chronic hepatitis C virus infection requires the use of pegylated interferon plus ribavirin. Treatment with these two agents has been associated with numerous side effects, which frequently include dermatologic eruptions. We report a cutaneous eruption associated wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark Naccarato (Author), Deborah Yoong (Author), Robert Solomon (Author), Mario Ostrowski (Author)
Format: Book
Published: PAGEPress Publications, 2013-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2a746d0c5b8b49b5841f1840f93c0ce5
042 |a dc 
100 1 0 |a Mark Naccarato  |e author 
700 1 0 |a Deborah Yoong  |e author 
700 1 0 |a Robert Solomon  |e author 
700 1 0 |a Mario Ostrowski  |e author 
245 0 0 |a Erythema annulare centrifugum-like eruption associated with pegylated interferon treatment for hepatitis C 
260 |b PAGEPress Publications,   |c 2013-07-01T00:00:00Z. 
500 |a 2036-7392 
500 |a 2036-7406 
500 |a 10.4081/dr.2013.e1 
520 |a Current standard of treatment for chronic hepatitis C virus infection requires the use of pegylated interferon plus ribavirin. Treatment with these two agents has been associated with numerous side effects, which frequently include dermatologic eruptions. We report a cutaneous eruption associated with interferon having clinical presentation of erythema annulare centrifugum. The eruption occurred within days of the first interferon injection and repeatedly flared following subsequent injections. Our patient was able to continue therapy without interruption, while managing the reaction with topical corticosteroid and oral antihistamine. We conclude that this is a benign cutaneous eruption associated with interferon which can be managed without dis- continuing treatment for hepatitis C. 
546 |a EN 
690 |a interferon, ribavirin, hepatitis C, erythema annulare centrifugum, drug eruption 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Dermatology Reports, Vol 5, Iss 1, Pp e1-e1 (2013) 
787 0 |n http://www.pagepress.org/journals/index.php/dr/article/view/4918 
787 0 |n https://doaj.org/toc/2036-7392 
787 0 |n https://doaj.org/toc/2036-7406 
856 4 1 |u https://doaj.org/article/2a746d0c5b8b49b5841f1840f93c0ce5  |z Connect to this object online.